Suven Life Sci
100% of moneycontrol users recommend buying Suven Life Sci.
What's your call on Suven Life Sci today?
Read 49 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3566.65||1.20||3581.70||2250.00||60,763.53|
|Sep' 14||Jun' 14||Mar' 14||Dec' 13|
|Scheme||No. of Shares|
|Reliance Capital Builder Fund - Series A (G)||186,424|
|IDFC Equity Opportunity - Series 1 - Direct Plan (Dividend Payout)||181,505|
|IDFC Equity Opportunity - Series 1 - Regular (Dividend Payout)||11,599|
|Reliance Capital Builder Fund - Series A - Direct Plan (G)||399|
DCB Bank Recommended on Aug 19th 2014
Recommended price 81.00 | Peak from reco 107.05 31.51%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Suven Life Sci is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,243.70 crore.The company has reported a standalone sales of Rs 139.83 crore and a Net Profit of Rs 24.84 crore for the quarter ended Sep 2014.
The company management includes Venkateswarlu Jasti - Chairman & CEO, Sudha Rani Jasti - Whole Time Director, M R Naidu - Director, K V Raghavan - Director, D G Prasad - Director, Syed E Hasnain - Director, M Gopala Krishna - Director.
It is listed on the BSE with a BSE Code of 530239 and the NSE with an NSE Code of SUVEN.
Its Registered office is at 8-2-334, SDE Serene Chambers, 6th Floor, Road No. 5,,Avenue 7, Hyderabad,Telangana - 500034.
Their Registrars are Karvy Computershare Private Ltd.